Lannett Company Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.0265
- Today's High:
- $0.0274
- Open Price:
- $0.0265
- 52W Low:
- $0.0102
- 52W High:
- $3.72
- Prev. Close:
- $0.0265
- Volume:
- 5990
Company Statistics
- Market Cap.:
- $7.38 million
- Book Value:
- -30.283
- Revenue TTM:
- $308.52 million
- Operating Margin TTM:
- -20.9%
- Gross Profit TTM:
- $46.10 million
- Profit Margin:
- -62.4%
- Return on Assets TTM:
- -7.8%
- Return on Equity TTM:
- 0%
Company Profile
Lannett Company Inc had its IPO on 1997-01-02 under the ticker symbol LCI.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Lannett Company Inc has a staff strength of 564 employees.
Stock update
Shares of Lannett Company Inc opened at $0.03 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.03 - $0.03, and closed at $0.03.
This is a +1.51% increase from the previous day's closing price.
A total volume of 5,990 shares were traded at the close of the day’s session.
In the last one week, shares of Lannett Company Inc have increased by +7.6%.
Lannett Company Inc's Key Ratios
Lannett Company Inc has a market cap of $7.38 million, indicating a price to book ratio of 1.8385 and a price to sales ratio of 0.0834.
In the last 12-months Lannett Company Inc’s revenue was $308.52 million with a gross profit of $46.10 million and an EBITDA of $-36590000. The EBITDA ratio measures Lannett Company Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Lannett Company Inc’s operating margin was -20.9% while its return on assets stood at -7.8% with a return of equity of 0%.
In Q1, Lannett Company Inc’s quarterly earnings growth was a negative -59.4% while revenue growth was a negative 6.5%.
Lannett Company Inc’s PE and PEG Ratio
- Forward PE
- 16.3934
- Trailing PE
- 0
- PEG
- -0.83
Its diluted EPS in the last 12-months stands at $-19.14 per share while it has a forward price to earnings multiple of 16.3934 and a PEG multiple of -0.83. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Lannett Company Inc’s profitability.
Lannett Company Inc stock is trading at a EV to sales ratio of 1.8426 and a EV to EBITDA ratio of -3.8632. Its price to sales ratio in the trailing 12-months stood at 0.0834.
Lannett Company Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $334.62 million
- Total Liabilities
- $733.08 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $1.40 million
- Dividend Payout Ratio
- 0%
Lannett Company Inc ended 2024 with $334.62 million in total assets and $0 in total liabilities. Its intangible assets were valued at $334.62 million while shareholder equity stood at $-412259000.00.
Lannett Company Inc ended 2024 with $0 in deferred long-term liabilities, $733.08 million in other current liabilities, 11000.00 in common stock, $-762183000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $46.54 million and cash and short-term investments were $46.54 million. The company’s total short-term debt was $630,470,000 while long-term debt stood at $0.
Lannett Company Inc’s total current assets stands at $261.72 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $68.15 million compared to accounts payable of $21.07 million and inventory worth $90.81 million.
In 2024, Lannett Company Inc's operating cash flow was $0 while its capital expenditure stood at $1.40 million.
Comparatively, Lannett Company Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.03
- 52-Week High
- $3.72
- 52-Week Low
- $0.0102
- Analyst Target Price
- $4
Lannett Company Inc stock is currently trading at $0.03 per share. It touched a 52-week high of $3.72 and a 52-week low of $3.72. Analysts tracking the stock have a 12-month average target price of $4.
Its 50-day moving average was $0.41 and 200-day moving average was $1.73 The short ratio stood at 29.56 indicating a short percent outstanding of 0%.
Around 1426.3% of the company’s stock are held by insiders while 3893% are held by institutions.
Frequently Asked Questions About Lannett Company Inc
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company’s product portfolio includes Amphetamine IR tablets, Amphetamine ER capsules, Dicyclomine tablets, Fluphenazine tablets, Levothyroxine capsules, Methylphenidate CD capsules, Methylphenidate ER, Posaconazole DR tablets, Probenecid tablets, and Verapamil SR tablets, as well as Numbrino nasal solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, Sinotherapeutics, Respirent Pharmaceuticals Co., Ltd., HEC Pharm Group, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was incorporated in 1942 and is headquartered in Trevose, Pennsylvania.